|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Alchemax_Corporation
|
|
gptkbp:awards
|
Innovation in Genetics 2101
Top Employer 2102
Best_Biotech_Company_2100
|
|
gptkbp:CEO
|
gptkb:John_Doe
gptkb:Richard_Roe
Jane_Smith
|
|
gptkbp:communityInvolvement
|
Educational Programs
Environmental Conservation
Local Health Initiatives
|
|
gptkbp:competitors
|
gptkb:Oscorp_Industries
gptkb:Hammer_Industries
gptkb:Roxon_Energy_Corporation
|
|
gptkbp:employees
|
5000
|
|
gptkbp:established
|
2099
|
|
gptkbp:foundedBy
|
gptkb:Alchemax_Corporation
|
|
gptkbp:foundedIn
|
2099
|
|
gptkbp:founder
|
gptkb:Alchemax_Corporation
|
|
gptkbp:hasSubsidiary
|
gptkb:Alchemax_Pharmaceuticals
Alchemax Bioengineering
Alchemax Genetics
|
|
gptkbp:headquarters
|
gptkb:New_York_City
gptkb:Manhattan,_New_York
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Alchemax Holdings
|
|
gptkbp:industry
|
Technology
|
|
gptkbp:keyPeople
|
CEO
CFO
CTO
|
|
gptkbp:market
|
$50 billion
|
|
gptkbp:operatesIn
|
Biotechnology
Genetics
Pharmaceuticals
|
|
gptkbp:parentCompany
|
gptkb:Alchemax_Corporation
|
|
gptkbp:partnerships
|
Government Agencies
Universities
Various Research Institutions
|
|
gptkbp:products
|
Pharmaceuticals
Genetic Enhancements
Biotech_Solutions
|
|
gptkbp:researchFocus
|
Genetic Engineering
Biotechnology Innovations
Pharmaceutical Development
|
|
gptkbp:revenue
|
$10 billion
|
|
gptkbp:stockSymbol
|
ALCH
|
|
gptkbp:subsidiary
|
gptkb:Alchemax_Pharmaceuticals
Alchemax Bioengineering
Alchemax Genetics
|
|
gptkbp:sustainabilityInitiatives
|
gptkb:Green_Technology
Renewable Energy
Waste Reduction Programs
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ
|
|
gptkbp:website
|
www.alchemax.com
|